<http://schema.org/articleBody>
" Scientists have discovered a molecule in blood which could help to predict whether lung cancer patients will respond to treatment. Patients with neuroendocrine small cell lung cancer (SCLC) are usually treated with a standard form of chemotherapy because there is currently no way to tell how well a patient will respond to treatment. However, Cancer Research UK-funded scientists hope that the latest discovery, which is published in the journal Clinical Cancer Research, could lead to a blood test which would help doctors make more informed decisions about the kind of treatment to use. Lesley Walker, director of cancer information at Cancer Research UK, commented: &amp;#039;This discovery is an important step to understanding how to treat lung cancer patients more efficiently. &amp;#039;Anything that improves our knowledge of how to best treat lung cancer is crucial work.&amp;#039; SCLC is one of the two main types of primary lung cancer, accounting for around one fifth of cases of the disease. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/healthy-living/news/a17582/blood-test-could-predict-effectiveness-of-lung-cancer-treatment/>